GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,517 Cr | ₹1,559 Cr | ₹871 Cr | ₹1,075 Cr | ₹671 Cr |
What is the latest Sundry Debtors ratio of GLAND PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹1,517 Cr |
Mar2024 | ₹1,559 Cr |
Mar2023 | ₹871 Cr |
Mar2022 | ₹1,075 Cr |
Mar2021 | ₹671 Cr |
How is Sundry Debtors of GLAND PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹1,517 Cr | -2.70 | |
Mar2024 | ₹1,559 Cr | 78.87 | |
Mar2023 | ₹871 Cr | -18.93 | |
Mar2022 | ₹1,075 Cr | 60.19 | |
Mar2021 | ₹671 Cr | - |
Compare Sundry Debtors of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,895.4 Cr | -1% | -4% | 13% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -1% |
-4% |
13% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses